Type / Class
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
Shares outstanding
264M
Number of holders
27
Total 13F shares, excl. options
14.2M
Shares change
-941K
Total reported value, excl. options
$17.6M
Value change
-$1.64M
Put/Call ratio
0.1
Number of buys
7
Number of sells
-18
Price
$1.24

Significant Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q3 2024

41 filings reported holding NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) as of Q3 2024.
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 14.2M shares of 264M outstanding shares and own 5.37% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (6.91M shares), Caligan Partners LP (3.5M shares), BOOTHBAY FUND MANAGEMENT, LLC (1.42M shares), Temasek Holdings (Private) Ltd (567K shares), TWO SIGMA ADVISERS, LP (499K shares), TWO SIGMA INVESTMENTS, LP (409K shares), EDBI Pte Ltd (222K shares), abrdn plc (163K shares), CITADEL ADVISORS LLC (98.4K shares), and Alberta Investment Management Corp (74.7K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.